An Act relative to PANDAS/PANS screening in medical/clinical settings
Committee recommended bill ought to pass and referred to the committee on House Ways and Means
Email me when H 5040 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 5040. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs that patients in medical or clinical environments be screened for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) and Pediatric Acute‑onset Neuropsychiatric Syndrome (PANS). It would affect healthcare providers and patients by establishing screening practices to identify these conditions earlier, aiming to improve diagnosis and treatment.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 5040
3 free questions a day, no accountHistory
- Reported from the committee on Financial Services
- Reported favorably by committee and referred to the committee on Health Care Financing
- New draft of H1249
Sponsors
- Joint Committee on Financial Services · sponsor
- Erika Uyterhoeven
- James B. Eldridge
- Kate Lipper-Garabedian
- Kathleen R. LaNatra
- Marcus S. Vaughn
- Paul McMurtry
- Samantha Montaño
- Steven Owens
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 5040 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 5040 freeOr ask your AI assistant about H 5040 directly:
Add to Claude, ChatGPT or Cursor